Phase IIa trial of diphencyprone in patients with viral warts

Trial Profile

Phase IIa trial of diphencyprone in patients with viral warts

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jul 2016

At a glance

  • Drugs Diphencyprone (Primary)
  • Indications Warts
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Hapten Pharmaceuticals
  • Most Recent Events

    • 22 Jul 2016 Summary of this trial will be presented at the 2016 Summer Meeting of the American Academy of Dermatology (AAD), according to a RXi Pharmaceuticals media release.
    • 07 Jan 2015 New trial record
    • 19 Dec 2014 This phase IIa trial has been completed, according to a RXi Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top